Two assaults that make the body less able to repair itself
For decades, the story of lung cancer has been largely the story of tobacco — but researchers at Ohio State University have introduced a troubling new chapter. A large case-control study finds that people who both vape and smoke face four times the lung cancer risk of smokers alone, offering the first evidence that these two habits, combined, create a danger greater than the sum of their parts. The finding arrives at a moment when younger generations are adopting vaping without fully understanding what it means to layer one inhalant habit atop another — a quiet compounding of risk that public health systems are only beginning to measure.
- A study of more than 32,000 participants found dual users of cigarettes and e-cigarettes are four times more likely to develop lung cancer than those who smoke alone — a risk gap stark enough to be called a first of its kind.
- Among lung cancer patients in the study, combined vaping and smoking was eight times more prevalent than in the cancer-free control group, suggesting the two products may interact synergistically rather than simply adding their harms together.
- Young people are adopting dual-use habits at accelerating rates, even as the long-term consequences remain poorly understood — a generational exposure unfolding faster than the science tracking it.
- Researchers are calling on regulators to examine inhaled flavorings and nicotine concentrations not in isolation, but in combination — a framing that challenges how the FDA currently approaches vaping and tobacco as separate regulatory problems.
- Backed by the National Cancer Institute and Ohio State's FDA-linked Tobacco Center of Regulatory Science, the findings are positioned to reach policymakers — though whether dual use will be treated as its own distinct hazard remains an open question.
Lung cancer remains the world's deadliest cancer, claiming 1.8 million lives in 2020, with tobacco smoke responsible for the vast majority of those deaths. But a new study from Ohio State University suggests the threat has grown more complex — and more urgent — than tobacco alone can explain.
Researchers conducted a case-control study comparing nearly 5,000 lung cancer patients against more than 27,000 cancer-free individuals from the same region of Ohio, matched by age, gender, and race. Their central question was whether combining cigarette smoking with e-cigarette use created a compounded danger. The answer was unambiguous: dual users were four times more likely to develop lung cancer than smokers who did not vape. More striking still, dual use appeared eight times more frequently among cancer patients than among the control group — a gap that points toward a synergistic interaction, not merely an additive one.
The study's authors, published in the Journal of Oncology Research and Therapy, argue that most people understand tobacco smoke carries carcinogens, but far fewer appreciate what chemicals vape vapor delivers to the lungs. Dr. Randall Harris, the study's corresponding author, and lead author Dr. Marisa Bittoni both emphasized that regulators need to scrutinize inhaled flavorings and nicotine concentrations in combination — not just as isolated products.
The concern is sharpest for younger generations. Bittoni noted that dual use is spreading among youth and young adults at a time when long-term effects are still poorly mapped, warning that a generation may be compounding risks it does not yet fully understand. Funded by the National Cancer Institute and housed within an FDA-linked research center, the study is designed to reach policymakers — though whether regulators will treat dual use as its own distinct public health problem, rather than two separate issues, remains to be seen.
Lung cancer kills more people than any other cancer worldwide—1.8 million deaths in 2020 alone. Tobacco smoke accounts for roughly 87 percent of those deaths. But a new study from Ohio State University suggests the picture is more complicated than tobacco use alone. Researchers have found that people who both vape and smoke face a dramatically steeper risk than smokers who don't vape at all.
The finding comes from a case-control study comparing nearly 5,000 people diagnosed with lung cancer against a control group of more than 27,000 people without the disease. All participants were drawn from the same geographic area around Columbus, Ohio, and matched on age, gender, and race. The researchers wanted to understand whether the combination of cigarette smoking and electronic cigarette use created a compounded danger—and the data delivered a clear answer. People who used both products were four times more likely to develop lung cancer than those who smoked cigarettes alone. The risk differential was stark enough that the researchers called it the first evidence of its kind: smoking and vaping together, not separately, as a distinct cancer hazard.
The numbers hint at something even more troubling. Among the lung cancer patients in the study, dual use of vaping and smoking was eight times more common than in the control group without cancer. That gap suggests the two products may interact in ways that amplify harm beyond what either one causes independently. The researchers published their work in the Journal of Oncology Research and Therapy, framing it as a warning that public health regulators need to pay attention to what happens when people combine these products.
Dr. Randall Harris, the study's corresponding author and a professor of epidemiology at Ohio State's College of Public Health, noted that while most people understand tobacco smoke contains carcinogens, far fewer grasp what chemicals enter the lungs through vape vapor. That knowledge gap matters, especially because the study raises questions about specific ingredients. The researchers argue that regulators should scrutinize inhaled flavorings and nicotine concentrations more carefully—not just in isolation, but in the context of how they interact with traditional smoking.
The concern extends beyond individual risk. Dr. Marisa Bittoni, the study's lead author, emphasized that dual use is spreading among young people and young adults at a time when the long-term health effects remain poorly understood. "This is especially concerning given the rate of youth and young adults using these products," she said. The implication is clear: a generation may be adopting a combination of habits without understanding the compounded danger they face. More research is needed, Bittoni argued, to give regulators the scientific foundation they need to make informed decisions about how these products should be controlled.
The study was funded by the National Cancer Institute and supported by Ohio State's Center for Tobacco Research, which operates as a Tobacco Center of Regulatory Science—a designation that means its work is specifically designed to inform the FDA's regulation of tobacco products. That institutional backing suggests the findings are likely to reach policymakers. What happens next depends on whether regulators treat dual use as a distinct public health problem requiring its own regulatory approach, or whether they continue to regulate vaping and smoking as separate issues.
Citas Notables
This study presents clear evidence showing that vaping in addition to smoking can increase your risk for lung cancer. This is especially concerning given the rate of youth and young adults using these products.— Dr. Marisa Bittoni, lead author, Ohio State College of Medicine
Most people know that tobacco smoke contains cancer-causing chemicals but, overall, there is less knowledge about the chemicals that are inhaled through vape vapors.— Dr. Randall Harris, corresponding author, Ohio State College of Public Health
La Conversación del Hearth Otra perspectiva de la historia
Why does combining vaping and smoking create such a dramatic increase in risk? Is it just additive—two bad things plus two bad things—or is something else happening?
The study doesn't fully explain the mechanism, but the numbers suggest it's not simply additive. If it were, you'd expect maybe a doubling of risk, not a quadrupling. The researchers hint that the chemicals in vape vapor may interact with tobacco smoke in ways that amplify damage to lung tissue. Think of it less like two separate assaults and more like two assaults that make the body less able to repair itself.
The study found dual use was eight times more common in cancer patients than in the control group. That's a bigger gap than the fourfold increased risk. What accounts for the difference?
That's the crucial distinction. The eightfold prevalence tells you how much more common dual use is among people who got cancer. The fourfold risk tells you how much more likely a dual user is to develop cancer compared to a smoker. Both numbers matter, but they're measuring different things. The prevalence gap suggests dual use is a strong marker of who gets sick; the risk ratio tells you how dangerous it actually is.
Why is this the first study to show this? Vaping has been around for over a decade. Shouldn't we have known this already?
Vaping is still relatively new in epidemiological terms. Most lung cancer studies have focused on traditional smoking because that's where the historical data is. You need large populations, long follow-up periods, and detailed exposure histories to detect these patterns. This study had the scale and the geographic consistency to spot something smaller studies might miss. But you're right—it's a gap in our knowledge that should have been filled sooner.
The researchers mention inhaled flavorings and nicotine concentrations specifically. Are those the culprits?
The study doesn't pinpoint them as the problem, but they're flagging them as unknowns that deserve regulatory attention. Flavorings are added to make vaping appealing, but we don't fully understand what happens when you inhale them chronically, especially in combination with tobacco smoke. Same with nicotine dose—vape products vary wildly in concentration, and we don't have good data on how that interacts with smoking.
The concern about youth adoption keeps coming up. Why is that the most urgent angle here?
Because young people who start dual use now won't show lung cancer symptoms for decades. By then, the habit may be entrenched, the products may be even more prevalent, and we'll have lost years we could have used to prevent exposure. It's a window-closing problem. Act now, or you're managing a crisis in 2050.